Literature DB >> 21067371

Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection.

Rebecca M Brotman1, Mark A Klebanoff, Tonja R Nansel, Kai F Yu, William W Andrews, Jun Zhang, Jane R Schwebke.   

Abstract

BACKGROUND: We sought to assess the relationship between bacterial vaginosis (BV) assessed by Gram stain and incident trichomonal, gonococcal, and/or chlamydial genital infection.
METHODS: This longitudinal study included 3620 nonpregnant women aged 15-44 years who presented for routine care at 12 clinics in Birmingham, Alabama. Participants were assessed quarterly for 1 year. Vaginal smears were categorized by the Nugent Gram stain score (0-3, normal; 4-6, intermediate state; 7-10, BV). Pooled logistic regression was used to estimate the hazard ratios for the comparison of trichomonal, gonococcal, and chlamydial infection incidence in participants by Nugent score at the prior visit. Participants were censored at their first visit with a positive test result for trichomonal, gonococcal, and/or chlamydial infection.
RESULTS: Of the 10,606 eligible visits, 37.96% were classified by BV and 13.3% by positive detection of trichomonal, gonococcal, and/or chlamydial infection. An intermediate state or BV at the prior visit was associated with a 1.5-2-fold increased risk for incident trichomonal, gonococcal, and/or chlamydial infection (adjusted hazard ratio [AHR] for intermediate state, 1.41 [95% confidence interval {CI}, 1.12-1.76]; AHR for BV, 1.73 [95% CI, 1.42-2.11]; P= .058 for trend). Estimates were similar for trichomonal-only, gonococcal-only, and chlamydial-only infection outcomes.
CONCLUSION: BV microbiota as gauged by Gram stain is associated with a significantly elevated risk for acquisition of trichomonal, gonococcal, and/or chlamydial genital infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21067371      PMCID: PMC3053135          DOI: 10.1086/657320

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

Review 1.  Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis.

Authors:  V Pybus; A B Onderdonk
Journal:  Microbes Infect       Date:  1999-04       Impact factor: 2.700

2.  Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis.

Authors:  J R Schwebke; S L Hillier; J D Sobel; J A McGregor; R L Sweet
Journal:  Obstet Gynecol       Date:  1996-10       Impact factor: 7.661

3.  Screening for bacterial vaginosis in pregnancy.

Authors:  J M Guise; S M Mahon; M Aickin; M Helfand; J F Peipert; C Westhoff
Journal:  Am J Prev Med       Date:  2001-04       Impact factor: 5.043

4.  Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.

Authors:  Jack D Sobel; Daron Ferris; Jane Schwebke; Paul Nyirjesy; Harold C Wiesenfeld; Jeffrey Peipert; David Soper; Suzanne E Ohmit; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

5.  Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain.

Authors:  V S Ocaña; A A Pesce De Ruiz Holgado; M E Nader-Macías
Journal:  Appl Environ Microbiol       Date:  1999-12       Impact factor: 4.792

6.  Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification.

Authors:  E R Boskey; K M Telsch; K J Whaley; T R Moench; R A Cone
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

8.  Vulvovaginal symptoms in women with bacterial vaginosis.

Authors:  Mark A Klebanoff; Jane R Schwebke; Jun Zhang; Tonja R Nansel; Kai-Fun Yu; William W Andrews
Journal:  Obstet Gynecol       Date:  2004-08       Impact factor: 7.661

9.  Disentangling contributions of reproductive tract infections to HIV acquisition in African Women.

Authors:  Janneke H H M van de Wijgert; Charles S Morrison; Joelle Brown; Cynthia Kwok; Barbara Van Der Pol; Tsungai Chipato; Josaphat K Byamugisha; Nancy Padian; Robert A Salata
Journal:  Sex Transm Dis       Date:  2009-06       Impact factor: 2.830

10.  The validity of teens' and young adults' self-reported condom use.

Authors:  Eve Rose; Ralph J Diclemente; Gina M Wingood; Jessica McDermott Sales; Teaniese P Latham; Richard A Crosby; Jonathan Zenilman; Johan Melendez; James Hardin
Journal:  Arch Pediatr Adolesc Med       Date:  2009-01
View more
  156 in total

Review 1.  The microbiota of the vagina and its influence on women's health and disease.

Authors:  David H Martin
Journal:  Am J Med Sci       Date:  2012-01       Impact factor: 2.378

Review 2.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

3.  Beyond Tryptophan Synthase: Identification of Genes That Contribute to Chlamydia trachomatis Survival during Gamma Interferon-Induced Persistence and Reactivation.

Authors:  Matthew K Muramatsu; Julie A Brothwell; Barry D Stein; Timothy E Putman; Daniel D Rockey; David E Nelson
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 4.  Maternal Microbiome and Pregnancy Outcomes That Impact Infant Health: A Review.

Authors:  Anne L Dunlop; Jennifer G Mulle; Erin P Ferranti; Sara Edwards; Alexis B Dunn; Elizabeth J Corwin
Journal:  Adv Neonatal Care       Date:  2015-12       Impact factor: 1.968

5.  Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections.

Authors:  Jennifer E Balkus; Lisa E Manhart; Jeannette Lee; Omu Anzala; Joshua Kimani; Jane Schwebke; Juma Shafi; Charles Rivers; Emanuel Kabare; R Scott McClelland
Journal:  J Infect Dis       Date:  2016-02-04       Impact factor: 5.226

6.  Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis.

Authors:  B Vitali; F Cruciani; G Picone; C Parolin; G Donders; L Laghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-18       Impact factor: 3.267

7.  Association between obesity and bacterial vaginosis as assessed by Nugent score.

Authors:  Rita T Brookheart; Warren G Lewis; Jeffrey F Peipert; Amanda L Lewis; Jenifer E Allsworth
Journal:  Am J Obstet Gynecol       Date:  2019-01-29       Impact factor: 8.661

8.  Use of a risk quiz to predict infection for sexually transmitted infections: a retrospective analysis of acceptability and positivity.

Authors:  Charlotte A Gaydos; Mary Jett-Goheen; Mathilda Barnes; Laura Dize; Perry Barnes; Yu-Hsiang Hsieh
Journal:  Sex Transm Infect       Date:  2015-08-18       Impact factor: 3.519

9.  Home Screening for Bacterial Vaginosis to Prevent Sexually Transmitted Diseases.

Authors:  Jane R Schwebke; Jeannette Y Lee; Shelly Lensing; Susan S Philip; Harold C Wiesenfeld; Arlene C Seña; Nikole Trainor; Nincoshka Acevado; Lisa Saylor; Ann M Rompalo; Robert L Cook
Journal:  Clin Infect Dis       Date:  2015-11-26       Impact factor: 9.079

10.  Associations between bacterial vaginosis, candida vaginitis, trichomonas vaginalis, and vaginal pathogenic community in Chinese women.

Authors:  Dandan Yuan; Wen Chen; Junjie Qin; Dongqian Shen; Youlin Qiao; Beihua Kong
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.